TransMedics Group, Inc.
TMDX
$133.81
-$8.12-5.72%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 181.16% | 2,288.73% | 580.13% | 241.70% | 191.22% |
| Total Depreciation and Amortization | 39.10% | 64.77% | 92.93% | 141.63% | 201.91% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 34.83% | -25.58% | -23.17% | -19.91% | -28.70% |
| Change in Net Operating Assets | 139.98% | 56.55% | -0.42% | -1.47% | -11.49% |
| Cash from Operations | 375.35% | 386.00% | 732.95% | 474.60% | 247.61% |
| Capital Expenditure | 63.70% | 54.97% | 42.28% | 14.56% | -40.04% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -100.00% | 102.96% | 102.96% | 102.96% | 102.96% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | 100.00% |
| Cash from Investing | 63.60% | 62.45% | 52.71% | 33.33% | -1.69% |
| Total Debt Issued | -- | -- | -- | -- | -100.00% |
| Total Debt Repaid | -- | -- | -- | -- | 100.00% |
| Issuance of Common Stock | -33.30% | 17.77% | 258.48% | 221.72% | 144.43% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 100.00% |
| Cash from Financing | -33.91% | 17.77% | -94.32% | -94.29% | -94.38% |
| Foreign Exchange rate Adjustments | 10.38% | 821.67% | 90.57% | -377.72% | 24.79% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 240.27% | 117.22% | -125.92% | -130.04% | -143.57% |